| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/10/2004 | EP1395602A2 Novel human potassium channel beta subunit |
| 03/10/2004 | EP1395285A2 Reagents and methods for modulating dkk-mediated interactions |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395278A2 Ocular tear growth factor-like protein |
| 03/10/2004 | EP1395275A2 Beta-secretase substrates and uses thereof |
| 03/10/2004 | EP1395274A2 Compositions and methods for inhibiting metastasis |
| 03/10/2004 | EP1395273A1 Targeted delivery of drugs for the treatment of viral infections |
| 03/10/2004 | EP1395227A2 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease |
| 03/10/2004 | EP1283901B1 Method and reagent kit for determining activity of 5'-nucleotidase |
| 03/10/2004 | EP1198554B1 Detection of micro-organisms |
| 03/10/2004 | EP1194535A4 Non-destructive cell-based assay |
| 03/10/2004 | EP1005572A4 Solid support with attached molecules |
| 03/10/2004 | EP0985148A4 Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage |
| 03/10/2004 | EP0909330B1 Diagnostic method and apparatus |
| 03/10/2004 | EP0771360B1 Method for the detection of the antibiotic resistance spectrum of mycobacterium species |
| 03/10/2004 | CN1481504A Screening assay for antagonists of human leukocyte receptors |
| 03/10/2004 | CN1481442A Novel primers for screening schizop hrenia and method thereof |
| 03/10/2004 | CN1481441A Transitnt electrical signal based methods and devices for oharacterizing molecular interaction and/or motor in sample |
| 03/10/2004 | CN1481440A Method for detection of viable microorganisms |
| 03/10/2004 | CN1481437A Method for in vitro culture of ovarian follicles |
| 03/10/2004 | CN1480732A Method of nano amplitication detection |
| 03/10/2004 | CN1480729A Improved method for detecting target molecule through granula combination |
| 03/10/2004 | CN1480728A System for testing quality of respirator and its testing method |
| 03/10/2004 | CN1480725A Full automatic cartridge unit for chip to be aligned and bonded |
| 03/10/2004 | CN1480724A Method for bonding and encapsulating plastic biochip and its device |
| 03/10/2004 | CN1480538A Quantitative measuring transgene component in transgene rapeseed and processed product |
| 03/10/2004 | CN1480537A Method for evaluating curative effect of medication to cure HIV through detecting change of TCR gene of human T cell receptor before and after treatment |
| 03/10/2004 | CN1480532A Gene of cortexin-3 receptor of pig melanin and method for detecting polymorphism of mononucleotide |
| 03/10/2004 | CN1480101A Mfg. system, its controller, control method, control system and control program |
| 03/10/2004 | CN1141572C Preparation of electrochemical biological sensor electrode for detecting bacteria |
| 03/10/2004 | CN1141399C Twin introducer used for homogeneous fluorescent PCR testing |
| 03/10/2004 | CN1141398C Polygenic amplification chip and preparing process thereof |
| 03/10/2004 | CN1141397C Method for making modular expression sequence label |
| 03/10/2004 | CN1141396C Encapsulation method of bacterial lipopolysaccharide, reagent kit and method of detecting specific lipopolysaccharide |
| 03/09/2004 | US6703493 Ob (obesity) polypeptides possess an ability to participate in the control of mammalian body weight; use in detection, monitoring, screening, and diagnosis of modulators of weight control; use in treatment/regulation of obesity in mammals |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703485 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 03/09/2004 | US6703248 Polymeric matrix having dissolved therein, a plasticizer a photosensitizer and a chemiluminescent compound; for use as bio assay |
| 03/09/2004 | US6703231 gM-negative EHV-mutants |
| 03/09/2004 | US6703228 Detecting single nucleotide polymorphisms (snp) and reduced complexity genomes; products and kits, e.g. panels of snp allele specific oligonucleotides, reduced complexity genomes, and databases for use in detection of snp's |
| 03/09/2004 | US6703216 Methods, compositions and apparatuses for detection of gamma-hydroxybutyric acid (GHB) |
| 03/09/2004 | US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity |
| 03/09/2004 | US6703214 Microscopic nematodes in functional high throughput in vivo assays for detection of inhibitors or activators of intestinal lipid uptake |
| 03/09/2004 | US6703213 Substrate analogs for MurG, methods of making same and assays using same |
| 03/09/2004 | US6703211 Cellular detection by providing high energy phosphate donor other than ADP to produce ATP |
| 03/09/2004 | US6703208 Involves contacting transglutaminase with glutenin to form complexes which is contacted with serum; detecting antibodies to the complexes |
| 03/09/2004 | US6703204 Method for assigning primary breast cancer tissues in a subject suspected of having breast cancer to either a high or low risk group |
| 03/09/2004 | US6703202 Evaluating and predicting clinical outcomes by gene expression analysis |
| 03/09/2004 | US6703199 Fibronectin type iii (fn3) polypeptide monobody; phase display library |
| 03/09/2004 | US6703197 Human methionine synthase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer |
| 03/09/2004 | US6703196 General purpose structure of an analytical element and its application for analyte determination |
| 03/09/2004 | US6702857 Membrane for use with implantable devices |
| 03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
| 03/09/2004 | CA2263992C Sequential hybridization of fungal cell dna and method for the detection of fungal cells in clinical material |
| 03/04/2004 | WO2004019264A1 Prediction by collective likelihood from emerging patterns |
| 03/04/2004 | WO2004019043A2 Polypeptide biomarkers for diagnosing alzheimer's disease |
| 03/04/2004 | WO2004019037A2 Method for analyzing body fluids for the presence of cancer cells, use thereof, corresponding analysis kits, and use of specific active substances for treating cancer |
| 03/04/2004 | WO2004019036A2 Method for identifying substances |
| 03/04/2004 | WO2004019025A1 Solid support and method of mass spectrometry of multiple substances or composites immobilized on the solid support through desorption/ionization |
| 03/04/2004 | WO2004019002A2 Fluorescent glycosides and methods for their use |
| 03/04/2004 | WO2004019001A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 03/04/2004 | WO2004018999A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 03/04/2004 | WO2004018998A2 Method using real-time pcr |
| 03/04/2004 | WO2004018996A2 High-throughput assay of hematopoietic stem and progenitor cell proliferation |
| 03/04/2004 | WO2004018992A2 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |
| 03/04/2004 | WO2004018712A1 OLIGONUCLEOTIDE TAGGED NUCLEOSIDE TRIPHOSPHATES (OTNTPs) FOR GENETIC ANALYSIS |
| 03/04/2004 | WO2004018711A2 Diagnostic test |
| 03/04/2004 | WO2004018710A2 Diagnosis of chronic rejection |
| 03/04/2004 | WO2004018709A2 Single nucleotide polymorphisms predicting adverse drug reactions and drug efficacy in cardiovascular disease |
| 03/04/2004 | WO2004018708A2 Genetic polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy |
| 03/04/2004 | WO2004018707A2 Method for identifying single nucleotide polymorphisms (snp) in genes which metabolize medicaments and test kit for carrying out said method |
| 03/04/2004 | WO2004018706A2 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 03/04/2004 | WO2004018705A1 High resolution analysis of genetic variation within cryptosporidium parvum |
| 03/04/2004 | WO2004018704A2 Point source biological agent detection system |
| 03/04/2004 | WO2004018701A2 Haplotype structures of chromosome 21 |
| 03/04/2004 | WO2004018696A2 Method for determining the allelic state of the 5'-end of the $g(a)s1-casein gene |
| 03/04/2004 | WO2004018691A1 A method for amplification micro-excised chromosomal dna and the use thereof |
| 03/04/2004 | WO2004018690A1 System and method for obtaining and maintaining high resistance seals in patch clamp recordings |
| 03/04/2004 | WO2004018689A1 Anti-neoplastic viruses |
| 03/04/2004 | WO2004018683A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 03/04/2004 | WO2004018680A1 Method of screening tumor antigen |
| 03/04/2004 | WO2004018670A1 Inhibitor of physiological activity of annexin 5 |
| 03/04/2004 | WO2004018669A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | WO2004018668A1 Method of evaluating degree of canceration of human-origin specimen |
| 03/04/2004 | WO2004018663A1 Hybridization sensing part, sensor chip, and hybridization method |
| 03/04/2004 | WO2004018648A2 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | WO2004018647A2 Methods and compositions for categorizing patients |
| 03/04/2004 | WO2004018642A2 Methods for detecting genes associated with bone properties and/or height |
| 03/04/2004 | WO2004018640A2 Preservation of rna quality and content in tissue sections during immunohistochemistry |
| 03/04/2004 | WO2004018632A2 High-throughput screen for modulators of chromatin modifying activity |
| 03/04/2004 | WO2004018627A2 Methods for propagating adenovirus and virus produced thereby |
| 03/04/2004 | WO2004018626A2 Abasic site endonuclease assay |
| 03/04/2004 | WO2004018619A2 P53 binding t cell receptor molecules and uses thereof |
| 03/04/2004 | WO2004018614A1 Apparatus for cell reaction examination and method of cell reaction examination |
| 03/04/2004 | WO2004018512A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 03/04/2004 | WO2004018504A2 Immune markers used for diagnosis and therapy in connection with transplant reactions |
| 03/04/2004 | WO2004018500A1 Coded nucleic acid carriers |
| 03/04/2004 | WO2004018497A2 Modified nucleotides for polynucleotide sequencing |
| 03/04/2004 | WO2004018493A1 Labelled nucleotides |
| 03/04/2004 | WO2004017997A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |